Recombinant DNA Technology Market size was valued at US$ 35.84 Bn in 2023 and the Medical segment dominated the growth of the Recombinant DNA Technology Market.
Recombinant DNA Technology Market Overview:
Enzymes are used in the recombinant DNA (rDNA) procedure to cut and paste desired DNA sequences. The rearranged DNA sequences can be put onto vectors, which move the DNA to an appropriate host cell so that it can express itself or be duplicated. Human proteins needed in disease therapy, such as growth hormone and insulin, have been produced in microbes using recombinant DNA technology.
Click here for a free sample link:
Market Scope:
Furthermore, the steady advancement of rDNA techniques has opened up new avenues for biopharmaceutical research by enabling the manufacture of a recombinant DNA molecule. Strong biopharmaceutical pipelines, especially those for recombinant proteins, are expected to hasten the uptake of this technology. The creation of recombinant products utilizing rDNA techniques in conjunction with ZFN, TALEN, and CRISPR/Cas9 nuclease, which allows for accurate and easy genome editing without being restricted by organisms, has contributed to the field's advancement. Numerous review investigations carried out by researchers in management have substantiated the efficacy of rDNA technology.
Segmentation:
by Product
Medical
Therapeutic Agent
Human Protein
Vaccine
Non-medical
Biotech Crops
Specialty Chemicals
Others
by Component
Expression System
Mammalian
Bacteria
Yeast
Baculovirus / insect
Others
Cloning Vector
by Application
Food & Agriculture
Health & Disease
Human
Animal
Environment
Others
by End-User
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
Key Players:
2. Fluxicon
3. Icaro Tech
4. Kofax
5. Lana Labs
6. Software AG
7. Fujitsu
8. CA Technologies
9. QPR Software
10.Cognitive Technology
11.Minit
12.Scheer
13.Worksoft
14.Puzzle Data
15.Your Data
16.Signavio
17.SNP
18.Recombinant DNA Technology Factory
19.StereoLOGIC
20.Deloitte
21.Broadcom
22.Intellera
23.UiPath
Regional Analysis:
North America: (Canada, Mexico, and the United States)
Europe (including Austria, Sweden, Germany, Italy, Spain, UK, and France)
Asia Pacific includes Bangladesh, Pakistan, Taiwan, Malaysia, Vietnam, South Korea, Japan, India, Australia, Indonesia, and the rest of APAC.
Africa and the Middle East (South Africa, GCC, Egypt, Nigeria, and the Remainder of ME&A)
South America (Argentina, Brazil, and the remaining portion)
COVID-19 Impact Analysis on Recombinant DNA Technology Market:
COVID-19 is an unprecedented worldwide public health emergency that has impacted practically every business, and the long-term effects are expected to influence industry growth throughout the projection period. Our ongoing study expands our research methodology to include fundamental COVID-19 concerns and potential next steps. The research provides insights on COVID-19 by considering changes in consumer behavior and demand, purchasing patterns, supply chain re-routing, the dynamics of contemporary market forces, and substantial government initiatives.
Key Questions Answered in the Recombinant DNA Technology Market Report are:
Which application area in the market for recombinant DNA technology is anticipated to grow to be the largest?
Who are the leading companies in the market for recombinant DNA technology?
Which major themes in the market for recombinant DNA technology are most likely to surface in the upcoming years?
By 2024, how big will the market be for recombinant DNA technology?
In 2030, which business accounted for the most portion of the market for recombinant DNA technology?
More Related reports:
About Us
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries, such as IT & telecom, chemicals, food & beverage, aerospace & defense, healthcare and others.
Our Address
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune-Banglore Highway, Narhe
Pune, Maharashtra, 411041, India.
✆ +91 9607365656
? [email protected]
? www.maximizemarketresearch.com
